Latest GLP-1 & Semaglutide News from India
Curated news on generic semaglutide launches, pricing, regulatory updates, and market developments in India. Sources include Bloomberg, CNBC, Business Today, and STAT News.
Recent Headlines
- Indian Government Warns GLP-1 Drugs Are Not Without Risks, Issues Advisory — Business Today, April 2026
- Novo Nordisk Further Cuts Semaglutide Prices Amid Generic Competition — Ozempic/Wegovy prices cut additional 30% — Business Today, March 2026
- India Is Launching Cheap Weight Loss Drugs That Could Disrupt the Global Market — 40+ generics at a fraction of global prices — CNBC, March 2026
- Generic Semaglutide Hits India: Prices Fall 90% Overnight — From ₹10,850 to ₹1,290 — Business Today, March 2026
- Dr. Reddy's Launches Obeda With Phase 3 Data — Only Indian generic with independent clinical trial — Business Standard, March 2026
- Generic Ozempic to Launch in India at $14 Per Month — vs $800+ US price — Bloomberg, March 2026
Check Your Eligibility | Compare Brands | Read Our Guides